Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Patrick M. Woster, PhD
Researcher SmartState Endowed Chair in Drug Discovery
Drug Discovery Building
Medical University of South Carolina
Room 405, MSC 140
70 President St.
Charleston, South Carolina, United States
Patrick M. Woster is professor of drug discovery and biomedical sciences at the South Carolina College of Pharmacy in Charleston, SC, and serves as the South Carolina SmartState Endowed Chair in Drug Discovery at the Medical University of South Carolina. He received a B.S. in pharmacy from the University of Nebraska Medical Center in 1978, and a Ph.D. in medicinal chemistry from the University of Nebraska – Lincoln in 1986.
Professor Woster maintains an active research program that has been funded by several agencies, including the National Institutes of Health, the World Health Association and the pharmaceutical industry. He has been a member of ACS and the Division of Medicinal Chemistry since 1979.
Woster’s research interests include the design, synthesis and evaluation of antitumor agents as well as the development of analogues with potent activity against a variety of cancer cell lines. Most recently, he has been working to develop a new gene-modifying sickle cell disease treatment, which could be fast-tracked to human clinical trials in as little as three years.
+myBinderRelated Content
-
Yvonne Carroll, RN, JDYvonne M. Carroll, RN, JD is the Directo...
-
Donald Rucknagel, MD, PhDDr. Rucknagel pioneered the use of incen...
-
Flying doctor takes to the skies after sister’s deathOlamide Orekunrin was studying to become...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
Emergency Guide: When to see the doctorIt is very important that every person o...
-
APHON/ASPHO Policy Statement for the Transition of Patients With Sickle Cell Disease From Pediatric to Adult Health ...With advances in medical care, the major...
-
Pfizer rare disease introduces Council for Change to further help SCD patientsFollowing a report earlier thi...
